BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K
1068 results:

  • 1. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
    Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
    Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Protective effect of quercetin on lipopolysaccharide‑induced miscarriage based on animal experiments and network pharmacology.
    Wu S; Tian Y; Zhang Q; Fu Z; Lan H; Zhou X; Ma L; Lou Y
    Mol Med Rep; 2024 Jun; 29(6):. PubMed ID: 38606505
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Transcriptome analysis of an AKT inhibitor-resistant endometrial cancer cell line.
    Onishi T; Takashima T; Shibahara K; Takagi S; Tanaka S; Mori M; Odashima H; Osawa Y; Hattori M
    Pharmacol Rep; 2024 Apr; 76(2):379-389. PubMed ID: 38478219
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Downregulation of LAMB3 Altered the Carcinogenic Properties of Human Papillomavirus 16-Positive Cervical cancer Cells.
    Wattanathavorn W; Seki M; Suzuki Y; Buranapraditkun S; Kitkumthorn N; Sasivimolrattana T; Bhattarakosol P; Chaiwongkot A
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473784
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. High TPX2 expression results in poor prognosis, and Sp1 mediates the coupling of the CX3CR1/CXCL10 chemokine pathway to the pi3k/Akt pathway through targeted inhibition of TPX2 in endometrial cancer.
    Yang M; Mao X; Li L; Yang J; Xing H; Jiang C
    Cancer Med; 2024 Mar; 13(5):e6958. PubMed ID: 38466034
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clonal origin and genomic diversity in Lynch syndrome-associated endometrial cancer with multiple synchronous tumors: Identification of the pathogenicity of MLH1 p.L582H.
    Takahashi K; Yachida N; Tamura R; Adachi S; Kondo S; Abé T; Umezu H; Nyuzuki H; Okuda S; Nakaoka H; Yoshihara K
    Genes Chromosomes Cancer; 2024 Mar; 63(3):e23231. PubMed ID: 38459936
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Periostin's role in uterine leiomyoma development: a mini-review on the potential periostin poses as a pharmacological intervention for uterine leiomyoma.
    Kiesler ZG; Hunter MI; Balboula AZ; Patterson AL
    Arch Gynecol Obstet; 2024 May; 309(5):1825-1831. PubMed ID: 38441600
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Twist-1 Stimulates the Malignant Behaviors of Hydatidiform Mole via the pi3k/AKT Pathway.
    Zhang C; Song Y; Yin Y; Hou H; Ge Z
    Discov Med; 2024 Feb; 36(181):286-293. PubMed ID: 38409834
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Chlamydia trachomatis enhances HPV persistence through immune modulation.
    Lu Y; Wu Q; Wang L; Ji L
    BMC Infect Dis; 2024 Feb; 24(1):229. PubMed ID: 38378486
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms.
    Heydarnia E; Dorostgou Z; Hedayati N; Mousavi V; Yahyazadeh S; Alimohammadi M; Gheibi M; Heidari P; Igder S; Mafi A; Vakili O
    Cell Commun Signal; 2024 Feb; 22(1):107. PubMed ID: 38341592
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Exploring a novel seven-gene marker and mitochondrial gene TMEM38A for predicting cervical cancer radiotherapy sensitivity using machine learning algorithms.
    Wang J; Mou X; Lu H; Jiang H; Xian Y; Wei X; Huang Z; Tang S; Cen H; Dong M; Liang Y; Shi G
    Front Endocrinol (Lausanne); 2023; 14():1302074. PubMed ID: 38327905
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pterostilbene upregulates MICA/B via the pi3k/AKT signaling pathway to enhance the capability of natural killer cells to kill cervical cancer cells.
    Li Z; Zhang J; You S; Zhang J; Zhang Y; Akram Z; Sun S
    Exp Cell Res; 2024 Feb; 435(2):113933. PubMed ID: 38296018
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. EphA2- and HDAC-Targeted Combination Therapy in Endometrial cancer.
    Joseph R; Dasari SK; Umamaheswaran S; Mangala LS; Bayraktar E; Rodriguez-Aguayo C; Wu Y; Nguyen N; Powell RT; Sobieski M; Liu Y; Kim MS; Corvigno S; Foster K; Hanjra P; Vu TC; Chowdhury MA; Amero P; Stephan C; Lopez-Berestein G; Westin SN; Sood AK
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279277
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Integrated genomic and transcriptomic analysis reveals the activation of pi3k signaling pathway in HPV-independent cervical cancers.
    Wang Y; He M; He T; Ouyang X; Shen X; Shi W; Huang S; Xiang L; Zou D; Jiang W; Yang H
    Br J Cancer; 2024 Apr; 130(6):987-1000. PubMed ID: 38253702
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Network pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer.
    Zhou J; Li H; Wu B; Zhu L; Huang Q; Guo Z; He Q; Wang L; Peng X; Guo T
    Sci Rep; 2024 Jan; 14(1):1860. PubMed ID: 38253629
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146.
    Makker V; Taylor MH; Aghajanian C; Cohn AL; Brose MS; Simone CD; Cao ZA; Suttner L; Loboda A; Cristescu R; Jelinic P; Orlowski R; Dutta L; Matsui J; Dutcus CE; Minoshima Y; Messing MJ
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38242717
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Whether specific genetic feature predicted immunotherapy efficacy: A case report.
    Chen J; Pang L; He L; Li T; Cheng X
    Medicine (Baltimore); 2024 Jan; 103(2):e36922. PubMed ID: 38215117
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. DHCR7 promotes lymph node metastasis in cervical cancer through cholesterol reprogramming-mediated activation of the KANK4/pi3k/AKT axis and VEGF-C secretion.
    Mei X; Xiong J; Liu J; Huang A; Zhu D; Huang Y; Wang H
    Cancer Lett; 2024 Mar; 584():216609. PubMed ID: 38211648
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. FOXM1 transcriptional regulation of RacGAP1 activates the pi3k/AKT signaling pathway to promote the proliferation, migration, and invasion of cervical cancer cells.
    Yao H; Li J; Zhou D; Pan X; Chu Y; Yin J
    Int J Clin Oncol; 2024 Mar; 29(3):333-344. PubMed ID: 38172354
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Systematic pan-cancer analysis of RNF186 with potential implications in progression and prognosis in human cancer.
    Hu Y; Jiang N; Wang X; Wu X; Bo J; Chen Y; Zeng Y; Wei X; Zhang H; Li M
    Life Sci; 2024 Feb; 338():122389. PubMed ID: 38160786
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 54.